WNR-14869-49107
3 vaccinations
3 coded responses
38 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 841 / UT
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QHK-33976-82456
Child or adolescent in my care · Male · 2021-11-08
RBB-31444-75301
Child or adolescent in my care · Male · 2021-11-10
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
-
2020-12-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
-
2021-01-06
Survey response — day 14, dose 1MedDRA: Pregnancy — Feeling: GoodFree text: Pregnancy associated nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — day 21, dose 1MedDRA: Migraine, Nausea, Pregnancy — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Pregnancy-associated nausea and migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Dose 2 — Pfizer-BioNTech
-
2021-01-15
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
-
2021-01-29
Survey response — day 14, dose 2MedDRA: Hyperthyroidism — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HyperthyroidismMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-02
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-04-16
- 2021-07-16
-
2021-11-06
Dose 3 — Pfizer-BioNTech
- 2021-11-06
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-11
-
2021-11-12
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-11
- 2021-12-18
- 2022-02-05
- 2022-05-07
- 2022-11-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-11-06 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-01-16 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-01-29 | Successful 2021-02-02 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 1 — day 14, dose 1
Symptoms: Pregnancy associated nausea
Release 1 — day 21, dose 1
Symptoms: Pregnancy-associated nausea and migraines
Release 3 — day 14, dose 2
Symptoms: Hyperthyroidism
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hyperthyroidism | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release